WallStreetZenWallStreetZen

NASDAQ: TXG
10x Genomics Inc Stock Forecast, Predictions & Price Target

Analyst price target for TXG

Based on 9 analysts offering 12 month price targets for 10x Genomics Inc.
Min Forecast
$26.00+15.1%
Avg Forecast
$43.00+90.35%
Max Forecast
$60.00+165.6%

Should I buy or sell TXG stock?

Based on 9 analysts offering ratings for 10x Genomics Inc.
Buy
Strong Buy
5 analysts 55.56%
Buy
0 analysts 0%
Hold
3 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
1 analysts 11.11%

Be the first to know when Wall Street analysts revise their TXG stock forecasts and price targets.

TXG stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-05-01
lockedlocked$00.00+00.00%2024-05-01
lockedlocked$00.00+00.00%2024-05-01
lockedlocked$00.00+00.00%2024-05-01
lockedlocked$00.00+00.00%2024-05-01
Canaccord Genuity
Bottom 4%
4
Strong BuyMaintains$50.00+121.34%2024-04-29
Deutsche Bank
Bottom 11%
11
Strong BuyMaintains$55.00+143.47%2024-04-18
Barclays
Bottom 3%
3
Strong BuyMaintains$45.00+99.20%2024-04-10
Guggenheim
Bottom 47%
47
Strong BuyInitiates Coverage On$60.00+165.60%2023-12-14

1 of 1

Forecast return on equity

Is TXG forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
17.32%

Forecast return on assets

Is TXG forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

TXG revenue forecast

What is TXG's revenue in the next 3 years based on estimates from 5 analysts?
Avg 1 year Forecast
$673.8M+7.73%
Avg 2 year Forecast
$777.5M+24.3%
Avg 3 year Forecast
$907.7M+45.12%
TXG's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TXG revenue growth forecast

How is TXG forecast to perform vs Health Information Services companies and vs the US market?
Company
12.02%
Industry
12.78%
Market
9.65%
TXG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TXG's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TXG vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
TXG$22.59$43.00+90.35%Buy
EVH$23.28$42.33+81.84%Strong Buy
CERT$16.73$19.10+14.17%Hold
GDRX$7.14$9.67+35.39%Strong Buy
PGNY$27.00$42.40+57.04%Strong Buy

10x Genomics Stock Forecast FAQ

Is 10x Genomics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NASDAQ: TXG) stock is to Buy TXG stock.

Out of 9 analysts, 5 (55.56%) are recommending TXG as a Strong Buy, 0 (0%) are recommending TXG as a Buy, 3 (33.33%) are recommending TXG as a Hold, 0 (0%) are recommending TXG as a Sell, and 1 (11.11%) are recommending TXG as a Strong Sell.

If you're new to stock investing, here's how to buy 10x Genomics stock.

What is TXG's revenue growth forecast for 2024-2026?

(NASDAQ: TXG) 10x Genomics's forecast annual revenue growth rate of 12.02% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 12.78%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.65%.

10x Genomics's revenue in 2024 is $625,448,000.On average, 5 Wall Street analysts forecast TXG's revenue for 2024 to be $80,657,023,562, with the lowest TXG revenue forecast at $80,324,353,846, and the highest TXG revenue forecast at $80,961,801,214. On average, 6 Wall Street analysts forecast TXG's revenue for 2025 to be $93,068,632,586, with the lowest TXG revenue forecast at $89,577,815,176, and the highest TXG revenue forecast at $95,953,485,945.

In 2026, TXG is forecast to generate $108,655,268,194 in revenue, with the lowest revenue forecast at $106,171,198,646 and the highest revenue forecast at $110,194,479,135.

What is TXG's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: TXG) forecast ROA is N/A, which is lower than the forecast US Health Information Services industry average of N/A.

What is TXG's Price Target?

According to 9 Wall Street analysts that have issued a 1 year TXG price target, the average TXG price target is $43.00, with the highest TXG stock price forecast at $60.00 and the lowest TXG stock price forecast at $26.00.

On average, Wall Street analysts predict that 10x Genomics's share price could reach $43.00 by May 1, 2025. The average 10x Genomics stock price prediction forecasts a potential upside of 90.35% from the current TXG share price of $22.59.

What is TXG's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: TXG) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.